文献速递糖尿病

芬兰儿童COVID-19疫苗接种、SARS-CoV-2感染与1型糖尿病

COVID-19 Vaccinations, SARS-CoV-2 Infections, and Type 1 Diabetes in Finnish Children.
PubMed 文献 · Diabetes Care · 2026-01-01

结果显示疫苗接种与1型糖尿病风险无显著关联(HR 1.30,95%CI 0.97–1.72,P=0.076),但接种疫苗与诊断时症状较轻相关;SARS-CoV-2感染与诊断时症状或自身抗体无关联。

要点

  • COVID-19疫苗接种与儿童1型糖尿病风险无显著关联(HR 1.30,95%CI 0.97–1.72,P=0.076)。
  • 接种疫苗与1型糖尿病诊断时症状较轻相关,且与胰岛素自身抗体阳性呈负相关。
  • SARS-CoV-2感染与1型糖尿病诊断时症状或自身抗体无关联。

核心结论

  • SARS-CoV-2疫苗接种与儿童1型糖尿病风险无显著关联。
  • 疫苗接种或SARS-CoV-2感染均不能解释疫情后芬兰儿童1型糖尿病诊断时症状更严重。
  • 接种疫苗的家长更可能寻求医疗照护,或致其子女诊断时症状较轻。

研究设计与样本

  • 每例患儿按年龄、性别、市镇匹配3名对照。
  • 疫苗接种信息来自国家疫苗接种登记;SARS-CoV-2感染基于诊断后不久样本中的循环抗体滴度判定。

主要发现

  • 诊断前COVID-19疫苗接种与1型糖尿病风险无显著关联(HR 1.30,95%CI 0.97–1.72,P=0.076)。
  • 疫苗接种与诊断时症状较轻相关。
  • 接种疫苗的病例中保护性HLA基因型更常见。
  • 疫苗接种与胰岛素自身抗体阳性呈负相关。
  • SARS-CoV-2感染与1型糖尿病诊断时症状或自身抗体无关联。

临床怎么用

  • 对于5–14岁儿童,COVID-19疫苗接种不增加1型糖尿病风险,可据此回应家长顾虑。
  • 诊断时症状较轻可能与接种疫苗家长的就医行为有关,需结合社会行为因素解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We assessed whether 1) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination is associated with the risk of type 1 diabetes and 2) SARS-CoV-2 vaccination or infection is associated with disease severity at type 1 diabetes diagnosis. RESEARCH DESIGN AND METHODS: Every Finnish child aged 5-14 years diagnosed with type 1 diabetes (case subjects, n = 433) during a 16-month period (September 2021 to December 2022) were compared with three control subjects matched for age, sex, and municipality. Information on coronavirus disease 2019 (COVID-19) vaccinations was obtained from the National Vaccination Register. SARS-CoV-2 infections were identified based on circulating antibody titer in samples obtained soon after the diagnosis of type 1 diabetes. RESULTS: COVID-19 vaccinations preceding type 1 diabetes diagnosis were not associated with risk of type 1 diabetes (hazard ratio 1.30, 95% CI 0.97-1.72, P = 0.076). Vaccinations were linked to less severe symptoms at the time of diagnosis. Children with protective HLA genotypes were more common among the vaccinated case subjects compared with unvaccinated case subjects. Vaccinations were inversely associated with insulin autoantibody positivity. There was no association between SARS-CoV-2 and type 1 diabetes symptoms or autoantibodies at the time of type 1 diabetes diagnosis. CONCLUSIONS: There was no significant association between SARS-CoV-2 vaccination and risk of type 1 diabetes. Neither COVID-19 vaccinations nor SARS-CoV-2 infections explain the more severe symptoms at type 1 diabetes diagnosis observed in Finnish children after the beginning of the COVID-19 pandemic. Parents who vaccinate their children are more likely to seek medical care. This may result in less severe symptoms in their children at diagnosis of diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Tall S, Pettersson J, Härkönen T, et al. COVID-19 Vaccinations, SARS-CoV-2 Infections, and Type 1 Diabetes in Finnish Children. Diabetes Care. 2026. PMID: 42085594. doi:10.2337/dc25-2913

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。